M2ara: Unraveling Metabolomic Drug Responses in Whole-cell MALDI Mass Spectrometry Bioassays

Overview

Journal Bioinformatics

Publisher Oxford University Press

Specialty Biology

Date 2024 Nov 19

PMID 39558590

Authors

Thomas Enzlein

Alexander Geisel

Carsten Hopf

Stefan Schmidt

Affiliations

Soon will be listed here.

Abstract

Summary: Fast computational evaluation and classification of concentration responses for hundreds of metabolites represented by their mass-to-charge (m/z) ratios is indispensable for unraveling complex metabolomic drug actions in label-free, whole-cell Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI MS) bioassays. In particular, the identification of novel pharmacodynamic biomarkers to determine target engagement, potency, and potential polypharmacology of drug-like compounds in high-throughput applications requires robust data interpretation pipelines. Given the large number of mass features in cell-based MALDI MS bioassays, reliable identification of true biological response patterns and their differentiation from any measurement artefacts that may be present is critical. To facilitate the exploration of metabolomic responses in complex MALDI MS datasets, we present a novel software tool, M2ara. Implemented as a user-friendly R-based shiny application, it enables rapid evaluation of Molecular High Content Screening (MHCS) assay data. Furthermore, we introduce the concept of Curve Response Score (CRS) and CRS fingerprints to enable rapid visual inspection and ranking of mass features. In addition, these CRS fingerprints allow direct comparison of cellular effects among different compounds. Beyond cellular assays, our computational framework can also be applied to MALDI MS-based (cell-free) biochemical assays in general.

Availability And Implementation: The software tool, code, and examples are available at https://github.com/CeMOS-Mannheim/M2ara and https://dx.doi.org/10.6084/m9.figshare.25736541.

References

Belov A, Kozole J, Bean M, Machutta C, Zhang G, Gao E . Acoustic Mist Ionization-Mass Spectrometry: A Comparison to Conventional High-Throughput Screening and Compound Profiling Platforms. Anal Chem. 2020; 92(20):13847-13854. DOI: 10.1021/acs.analchem.0c02508. View

Wu N, Nishioka W, Derecki N, Maher M . High-throughput-compatible assays using a genetically-encoded calcium indicator. Sci Rep. 2019; 9(1):12692. PMC: 6722131. DOI: 10.1038/s41598-019-49070-8. View

Pu F, Radosevich A, Bruckner B, Fontaine D, Panchal S, Williams J . New Platform for Label-Free, Proximal Cellular Pharmacodynamic Assays: Identification of Glutaminase Inhibitors Using Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry. ACS Chem Biol. 2023; 18(4):942-948. DOI: 10.1021/acschembio.3c00087. View

Wang D, Hensman J, Kutkaite G, Toh T, Galhoz A, Dry J . A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates. Elife. 2020; 9. PMC: 7746236. DOI: 10.7554/eLife.60352. View

Simon R, Habe T, Ries R, Winter M, Wang Y, Fernandez-Montalvan A . Acoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery. SLAS Discov. 2021; 26(8):961-973. DOI: 10.1177/24725552211028135. View

Di Veroli G, Fornari C, Goldlust I, Mills G, Koh S, Bramhall J . An automated fitting procedure and software for dose-response curves with multiphasic features. Sci Rep. 2015; 5:14701. PMC: 4589737. DOI: 10.1038/srep14701. View

Ritz C, Baty F, Streibig J, Gerhard D . Dose-Response Analysis Using R. PLoS One. 2015; 10(12):e0146021. PMC: 4696819. DOI: 10.1371/journal.pone.0146021. View

Yeyeodu S, Witherspoon S, Gilyazova N, Ibeanu G . A rapid, inexpensive high throughput screen method for neurite outgrowth. Curr Chem Genomics. 2011; 4:74-83. PMC: 3040990. DOI: 10.2174/1875397301004010074. View

Bayer F, Gander M, Kuster B, The M . CurveCurator: a recalibrated F-statistic to assess, classify, and explore significance of dose-response curves. Nat Commun. 2023; 14(1):7902. PMC: 10689459. DOI: 10.1038/s41467-023-43696-z. View

10.

Weigt D, Parrish C, Krueger J, Oleykowski C, Rendina A, Hopf C . Mechanistic MALDI-TOF Cell-Based Assay for the Discovery of Potent and Specific Fatty Acid Synthase Inhibitors. Cell Chem Biol. 2019; 26(9):1322-1331.e4. DOI: 10.1016/j.chembiol.2019.06.004. View

11.

Simon R, Winter M, Kleiner C, Ries R, Schnapp G, Heimann A . MALDI-TOF Mass Spectrometry-Based High-Throughput Screening for Inhibitors of the Cytosolic DNA Sensor cGAS. SLAS Discov. 2019; 25(4):372-383. DOI: 10.1177/2472555219880185. View

12.

Koch M, Enzlein T, Chen S, Petit D, Lismont S, Zacharias M . APP substrate ectodomain defines amyloid-β peptide length by restraining γ-secretase processivity and facilitating product release. EMBO J. 2023; 42(23):e114372. PMC: 10690472. DOI: 10.15252/embj.2023114372. View

13.

Unger M, Schumacher L, Enzlein T, Weigt D, Zamek-Gliszczynski M, Schwab M . Direct Automated MALDI Mass Spectrometry Analysis of Cellular Transporter Function: Inhibition of OATP2B1 Uptake by 294 Drugs. Anal Chem. 2020; 92(17):11851-11859. DOI: 10.1021/acs.analchem.0c02186. View

14.

Schmidt S, Geisel A, Enzlein T, Frohlich B, Pritchett L, Verneret M . Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay. Sci Rep. 2024; 14(1):21462. PMC: 11399240. DOI: 10.1038/s41598-024-71483-3. View

15.

Duenas M, Peltier-Heap R, Leveridge M, Annan R, Buttner F, Trost M . Advances in high-throughput mass spectrometry in drug discovery. EMBO Mol Med. 2022; 15(1):e14850. PMC: 9832828. DOI: 10.15252/emmm.202114850. View

16.

Gibb S, Strimmer K . MALDIquant: a versatile R package for the analysis of mass spectrometry data. Bioinformatics. 2012; 28(17):2270-1. DOI: 10.1093/bioinformatics/bts447. View

17.

Willems S, Voytik E, Skowronek P, Strauss M, Mann M . AlphaTims: Indexing Trapped Ion Mobility Spectrometry-TOF Data for Fast and Easy Accession and Visualization. Mol Cell Proteomics. 2021; 20:100149. PMC: 8526765. DOI: 10.1016/j.mcpro.2021.100149. View

18.

De Cesare V, Moran J, Traynor R, Knebel A, Ritorto M, Trost M . High-throughput matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry-based deubiquitylating enzyme assay for drug discovery. Nat Protoc. 2020; 15(12):4034-4057. DOI: 10.1038/s41596-020-00405-0. View

19.

Weigt D, Sammour D, Ulrich T, Munteanu B, Hopf C . Automated analysis of lipid drug-response markers by combined fast and high-resolution whole cell MALDI mass spectrometry biotyping. Sci Rep. 2018; 8(1):11260. PMC: 6062520. DOI: 10.1038/s41598-018-29677-z. View

20.

Unger M, Blank M, Enzlein T, Hopf C . Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry. Nat Protoc. 2021; 16(12):5533-5558. DOI: 10.1038/s41596-021-00624-z. View